InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Raw Materials (2023 - 2025)

InflaRx's (IFRX) quarterly Raw Materials came in at $92922.6 in Q2 2025, down 37.66% year-over-year from $149056.3 in Q2 2024, and up 5.93% quarter-over-quarter from $87717.8 in Q4 2024.

Analysis

InflaRx (IFRX) Raw Materials (2023 - 2025) Analysis & Trends

InflaRx has disclosed Raw Materials across 3 years of filings, most recently posting $92922.6 for Q2 2025.

  • In Q2 2025, Raw Materials fell 37.66% year-over-year to $92922.6; the TTM figure through Jun 2025 stood at $92922.6 (down 37.66% YoY), while the FY2024 annual figure was $87717.8, down 80.75% from the prior year.
  • Raw Materials came in at $92922.6 for Q2 2025 at InflaRx, up from $87717.8 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $455725.1 in Q4 2023 to a low of $87717.8 in Q4 2024.
  • Average Raw Materials over 3 years is $196355.4, with a median of $120989.4 recorded in 2024.
  • Year-over-year, Raw Materials tumbled 80.75% in 2024 and tumbled 37.66% in 2025.
  • Over 3 years, Raw Materials stood at $455725.1 in 2023, then plunged by 80.75% to $87717.8 in 2024, then grew by 5.93% to $92922.6 in 2025.
  • Per Business Quant data, the three most recent Raw Materials figures were $92922.6 in Q2 2025, $87717.8 in Q4 2024, and $149056.3 in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 92,922.57
Dec 31, 2024 87,717.79
Jun 30, 2024 149,056.32
Dec 31, 2023 455,725.11